LO-PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LO-PHARMA
Largest movements
- Tangible fixed assets -€45,697
down €45,697 (-12.2%), from €374,555 to €328,858
- Receivables within one year -€41,432
down €41,432 (-41.5%), from €99,855 to €58,423
of which Other amounts receivable: -€29,385
- Cash -€15,318
down €15,318 (-22.2%), from €69,093 to €53,775
mainly Debts after one year (-€68,305) and Net result for the year (-€15,388)
- Debts after one year -€68,305
down €68,305 (-21.6%), from €316,598 to €248,292
- Profit (loss) carried forward -€15,388
down €15,388 (-21.3%), from €72,387 to €57,000
- Trade debts -€10,116
down €10,116 (-17.5%), from €57,811 to €47,695
- Other debts -€7,018
down €7,018 (-7.4%), from €94,429 to €87,411
- Gross operating margin -€38,288
down €38,288 (-20.3%), from €188,417 to €150,129
- Taxes -€9,580
no longer reported in 2025 (was €9,580)
- Staff costs +€5,640
up €5,640 (+6.7%), from €84,326 to €89,967
- Financial income -€1,995
down €1,995 (-99.3%), from €2,009 to €14
of which Non-recurring financial income: -€1,997
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €698,997 | €597,566 | -€101,431 | -14.5% |
| Fixed assets | 21/28 | €374,555 | €328,858 | -€45,697 | -12.2% |
| Tangible fixed assets | 22/27 | €374,555 | €328,858 | -€45,697 | -12.2% |
| Land and buildings | 22 | €299,229 | €279,902 | -€19,327 | -6.5% |
| Plant, machinery and equipment | 23 | €47,916 | €28,498 | -€19,418 | -40.5% |
| Furniture and vehicles | 24 | €27,410 | €20,457 | -€6,952 | -25.4% |
| Current assets | 29/58 | €324,442 | €268,709 | -€55,734 | -17.2% |
| Stocks and contracts in progress | 3 | €152,346 | €150,254 | -€2,092 | -1.4% |
| Stocks | 30/36 | €152,346 | €150,254 | -€2,092 | -1.4% |
| Amounts receivable within one year | 40/41 | €99,855 | €58,423 | -€41,432 | -41.5% |
| Trade receivables | 40 | €63,247 | €51,199 | -€12,048 | -19.0% |
| Other amounts receivable | 41 | €36,608 | €7,224 | -€29,385 | -80.3% |
| Cash at bank and in hand | 54/58 | €69,093 | €53,775 | -€15,318 | -22.2% |
| Deferred charges and accrued income | 490/1 | €3,148 | €6,257 | +€3,109 | +98.7% |
| Total equity and liabilities | 10/49 | €698,997 | €597,566 | -€101,431 | -14.5% |
| Equity | 10/15 | €94,523 | €79,136 | -€15,388 | -16.3% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €2,136 | €2,136 | = | 0.0% |
| Tax-exempt reserves | 132 | €136 | €136 | = | 0.0% |
| Distributable reserves | 133 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €72,387 | €57,000 | -€15,388 | -21.3% |
| Amounts payable | 17/49 | €604,474 | €518,431 | -€86,043 | -14.2% |
| Amounts payable after more than one year | 17 | €316,598 | €248,292 | -€68,305 | -21.6% |
| Financial debts | 170/4 | €316,598 | €248,292 | -€68,305 | -21.6% |
| Amounts payable within one year | 42/48 | €284,788 | €265,382 | -€19,407 | -6.8% |
| Current portion of amounts payable after more than one year | 42 | €65,029 | €68,305 | +€3,276 | +5.0% |
| Financial debts | 43 | €50,000 | €50,000 | = | 0.0% |
| Credit institutions | 430/8 | €50,000 | €50,000 | = | 0.0% |
| Trade debts | 44 | €57,811 | €47,695 | -€10,116 | -17.5% |
| Suppliers | 440/4 | €57,811 | €47,695 | -€10,116 | -17.5% |
| Taxes, remuneration and social security | 45 | €17,519 | €11,971 | -€5,549 | -31.7% |
| Taxes | 450/3 | €1,526 | €1,064 | -€462 | -30.3% |
| Remuneration and social security | 454/9 | €15,993 | €10,907 | -€5,087 | -31.8% |
| Other amounts payable | 47/48 | €94,429 | €87,411 | -€7,018 | -7.4% |
| Accrued charges and deferred income | 492/3 | €3,088 | €4,757 | +€1,669 | +54.1% |
| Remuneration, social security and pensions | 62 | €84,326 | €89,967 | +€5,640 | +6.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €51,636 | €50,959 | -€676 | -1.3% |
| Other operating charges | 640/8 | €3,115 | €3,368 | +€252 | +8.1% |
| Non-recurring operating charges | 66A | - | €1,936 | +€1,936 | |
| Gross operating margin | 9900 | €188,417 | €150,129 | -€38,288 | -20.3% |
| Operating profit (loss) | 9901 | €49,339 | €3,900 | -€45,440 | -92.1% |
| Financial income | 75/76B | €2,009 | €14 | -€1,995 | -99.3% |
| Recurring financial income | 75 | €12 | €14 | +€2 | +13.7% |
| Non-recurring financial income | 76B | €1,997 | - | -€1,997 | |
| Financial charges | 65/66B | €19,874 | €19,301 | -€573 | -2.9% |
| Recurring financial charges | 65 | €19,874 | €19,301 | -€573 | -2.9% |
| Profit (loss) for the period before taxes | 9903 | €31,474 | -€15,388 | -€46,861 | |
| Income taxes | 67/77 | €9,580 | - | -€9,580 | |
| Profit (loss) for the period | 9904 | €21,894 | -€15,388 | -€37,281 | |
| Profit (loss) for the period to be appropriated | 9905 | €21,894 | -€15,388 | -€37,281 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.